NeuroStar® Marks Two Years of Transformative Impact with NeuroStar University
August 20, 2024 08:29 ET
|
Neuronetics
MALVERN, Pa., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month
August 01, 2024 08:29 ET
|
Neuronetics
MALVERN, Pa., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Aetna Policy Update Expands TMS Availability for Adolescents With Depression
July 22, 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults
July 11, 2024 08:36 ET
|
Neuronetics
MALVERN, Pa., July 11, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents
July 10, 2024 08:32 ET
|
Neuronetics
MALVERN, Pa., July 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar® Launches Better Me Provider Program Nationwide
July 01, 2024 08:02 ET
|
Neuronetics
MALVERN, Pa., July 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting
June 13, 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., June 13, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
May 15, 2024 07:32 ET
|
Neuronetics
MALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
May 01, 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
April 10, 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...